Kobra Rostamizadeh Selected Research

didodecyldimethylammonium

3/2022	Co-delivery of siRNA and lycopene encapsulated hybrid lipid nanoparticles for dual silencing of insulin-like growth factor 1 receptor in MCF-7 breast cancer cell line.
1/2021	Apoptosis induction by siRNA targeting integrin-β1 and regorafenib/DDAB-mPEG-PCL hybrid nanoparticles in regorafenib-resistant colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kobra Rostamizadeh Research Topics

Disease

12	Neoplasms (Cancer) 03/2022 - 05/2014
3	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2019
3	Hemolysis 05/2021 - 11/2018
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 02/2018
1	Weight Loss (Weight Reduction) 01/2022
1	Echinococcosis (Hydatid Cysts) 12/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Memory Disorders (Memory Loss) 01/2020
1	Central Nervous System Diseases (CNS Diseases) 07/2019
1	HIV Infections (HIV Infection) 05/2019
1	Malaria 01/2019
1	Cysts 11/2018
1	Lung Neoplasms (Lung Cancer) 11/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2017

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2022 - 05/2014
5	methoxy poly(ethylene glycol-co-epsilon-caprolactone)IBA 03/2022 - 02/2018
4	CurcuminIBA 01/2021 - 12/2014
4	MicellesIBA 07/2019 - 12/2014
3	Ethylene Glycol (Monoethylene Glycol)IBA 03/2022 - 02/2018
3	polycaprolactoneIBA 03/2022 - 02/2018
3	LipidsIBA 03/2022 - 01/2019
2	didodecyldimethylammoniumIBA 03/2022 - 01/2021
2	dimethyldioctadecylammonium (dimethyldioctadecylammonium chloride)IBA 03/2022 - 01/2021
2	Small Interfering RNA (siRNA)IBA 03/2022 - 01/2021
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 03/2016
2	Methotrexate (Mexate)FDA LinkGeneric 05/2021 - 01/2019
2	Therapeutic UsesIBA 01/2021 - 03/2019
2	Protons (Proton)IBA 08/2020 - 11/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 05/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2022
1	LigandsIBA 03/2022
1	LycopeneIBA 03/2022
1	Insulin-Like PeptidesIBA 03/2022
1	Lipid NanoparticlesIBA 03/2022
1	Insulin (Novolin)FDA Link 03/2022
1	PolymersIBA 01/2022
1	Albendazole (Albenza)FDA Link 12/2021
1	ProdrugsIBA 05/2021
1	monomethoxypolyethylene glycol (MPEG)IBA 01/2021
1	caprolactoneIBA 01/2021
1	regorafenibIBA 01/2021
1	GlucosidesIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	SolutionsIBA 01/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2019
1	Indinavir (Crixivan)FDA Link 05/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2019
1	Drug CombinationsIBA 03/2019
1	flubendazoleIBA 11/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2018
1	pyruvate dehydrogenase kinase 4IBA 02/2018
1	IntegrinsIBA 02/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2018
1	NanogelsIBA 08/2017
1	Contrast MediaIBA 03/2016
1	Drug CarriersIBA 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 12/2014

Therapy/Procedure

5	Therapeutics 11/2019 - 03/2016
1	Precision Medicine 03/2016